Centro de Investigaciones Endocrinológicas "Dr. César Bergadá" CONICET-FEI-División de Endocrinología, Hospital de Niños R. Gutierrez, Buenos Aires, Argentina.
Instituto de Investigaciones Bioquímicas de La Plata, CONICET, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.
Front Endocrinol (Lausanne). 2022 Apr 27;13:849279. doi: 10.3389/fendo.2022.849279. eCollection 2022.
Gliomas are the most frequent solid tumors in children. Among these, high-grade gliomas are less common in children than in adults, though they are similar in their aggressive clinical behavior. In adults, glioblastoma is the most lethal tumor of the central nervous system. Insulin-like growth factor 1 receptor (IGF1R) plays an important role in cancer biology, and its nuclear localization has been described as an adverse prognostic factor in different tumors. Previously, we have demonstrated that, in pediatric gliomas, IGF1R nuclear localization is significantly associated with high-grade tumors, worst clinical outcome, and increased risk of death. Herein we explore the role of IGF1R intracellular localization by comparing two glioblastoma cell lines that differ only in their IGF1R capacity to translocate to the nucleus. , IGF1R nuclear localization enhances glioblastoma cell motility and metabolism without affecting their proliferation. , IGF1R has the capacity to translocate to the nucleus and allows not only a higher proliferation rate and the earlier development of tumors but also renders the cells sensitive to OSI906 therapy. With this work, we provide evidence supporting the implications of the presence of IGF1R in the nucleus of glioma cells and a potential therapeutic opportunity for patients harboring gliomas with IGF1R nuclear localization.
神经胶质瘤是儿童最常见的实体肿瘤。在这些肿瘤中,高级别神经胶质瘤在儿童中的发病率低于成人,但它们具有相似的侵袭性临床行为。在成人中,胶质母细胞瘤是中枢神经系统中最致命的肿瘤。胰岛素样生长因子 1 受体(IGF1R)在癌症生物学中发挥重要作用,其核定位已被描述为不同肿瘤的不良预后因素。此前,我们已经证明,在儿童神经胶质瘤中,IGF1R 核定位与高级别肿瘤、最差的临床结局和死亡风险增加显著相关。在这里,我们通过比较两种仅在 IGF1R 向核易位能力上存在差异的胶质母细胞瘤细胞系,来探讨 IGF1R 细胞内定位的作用。结果表明,IGF1R 核定位增强了胶质母细胞瘤细胞的迁移和代谢能力,而不影响其增殖。此外,IGF1R 具有向核易位的能力,不仅允许更高的增殖率和肿瘤的更早发展,而且使细胞对 OSI906 治疗敏感。通过这项工作,我们提供了支持 IGF1R 存在于神经胶质瘤细胞核中以及为携带 IGF1R 核定位的神经胶质瘤患者提供潜在治疗机会的证据。